Display Settings:

Format

Send to:

Choose Destination

    Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10146-51.

    ATM binds to beta-adaptin in cytoplasmic vesicles.

    Lim DS, Kirsch DG, Canman CE, Ahn JH, Ziv Y, Newman LS, Darnell RB, Shiloh Y, Kastan MB.

    Oncology Center, The Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.

    Inherited mutations in the ATM gene lead to a complex clinical phenotype characterized by neuronal degeneration, oculocutaneous telangiectasias, immune dysfunction, and cancer predisposition. Using the yeast two-hybrid system, we demonstrate that ataxia telangiectasia mutated (ATM) binds to beta-adaptin, one of the components of the AP-2 adaptor complex, which is involved in clathrin-mediated endocytosis of receptors. The interaction between ATM and beta-adaptin was confirmed in vitro, and coimmunoprecipitation and colocalization studies show that the proteins also associate in vivo. ATM also interacts in vitro with beta-NAP, a neuronal-specific beta-adaptin homolog that was identified as an autoantigen in a patient with cerebellar degeneration. Our data describing the association of ATM with beta-adaptin in vesicles indicate that ATM may play a role in intracellular vesicle and/or protein transport mechanisms.

    PMID: 9707615 [PubMed - indexed for MEDLINE]

    PMCID: 21476

    Supplemental Content

    Click here to read Click here to read